NaomiFujiokaMD
Oncology • Minneapolis, MNHead & Neck Cancer, Thoracic Cancer
Associate Professor, Division of Hematology, Oncology and Transplantation
Dr. Fujioka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Fulton St SE
Minneapolis, MN 55455Phone+1 612-625-3600
Summary
- Research areas
- Chemoprevention of tobacco-related lung cancer using food- and nutrient-derived compounds
- Clinical Trials
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2007 - 2010- University of MinnesotaResidency, Internal Medicine, 2004 - 2007
- University of Minnesota Medical SchoolClass of 2004
Certifications & Licensure
MN State Medical License 2007 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Investigation of Kava Effects on NNK Metabolism Start of enrollment: 2015 Dec 03
- Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism Start of enrollment: 2016 Dec 01
- Effect of Kava on Anxiety and Stress in Cancer Survivors Start of enrollment: 2024 Jun 01
Roles: Contact
Publications & Presentations
PubMed
- Improving Patient Understanding and Outcomes in Lung Cancer Using an Animated Patient's Guide with Visual Formats of Learning.Manish R Patel, Abbie Begnaud, Shanda H Blackmon, Arkadiusz Z Dudek, Naomi Fujioka
Journal of Cancer Education. 2024-10-22 - One-Week Kava Dietary Supplementation Increases Both Urinary- and-Glucuronides of NNAL, a Lung Carcinogen Major Metabolite, among Smokers.Qi Hu, Zhixin Tang, Allison Lynch, Breanne Freeman, Naomi Fujioka
Chemical Research in Toxicology. 2024-09-16 - Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortiu...Jyoti Malhotra, Alberto Chiappori, Naomi Fujioka, Nasser H Hanna, Lawrence E Feldman
Lung Cancer. 2024-09-01
Press Mentions
Lung Cancer Awareness with the U of M: Smoking, Radon, and Cancer Treatment and PreventionNovember 11th, 2021
OncLive® Presents State of the Science Summit™ on Lung CancerAugust 1st, 2019
Professional Memberships
- Member
- Member
- International Association for the Study of Lung Cancer (IASLC)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
